Limits to submaximal and maximal exercise in patients with hypertrophic cardiomyopathy

被引:6
|
作者
MacNamara, James P. [1 ,2 ]
Dias, Katrin A. [1 ,2 ]
Hearon, Christopher M., Jr. [1 ,2 ]
Hieda, Michinari [1 ,2 ,3 ]
Turer, Aslan T. [2 ]
Link, Mark S. [2 ]
Sarma, Satyam [1 ,2 ]
Levine, Benjamin D. [1 ,2 ]
机构
[1] Texas Hlth Presbyterian Dallas, Inst Exercise & Environm Med, Dallas, TX 75231 USA
[2] Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA
[3] Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Japan
关键词
cardiac output; exercise limitations; hypertrophic cardiomyopathy; metabolic demand; LEFT-VENTRICULAR HYPERTROPHY; CARDIAC-OUTPUT; HEART-FAILURE; SYMPTOMATIC PATIENTS; CAPACITY; UTILITY;
D O I
10.1152/japplphysiol.00566.2021
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Patients with hypertrophic cardiomyopathy (HCM) often have reduced exercise capacity, and it is unclear whether cardiovascular regulation during exercise is intact in these patients. We aimed to determine the relationship between cardiac output (Q_c) and oxygen uptake (V_O2), and stroke volume (SV) reserve in HCM compared with healthy participants and participants with left ven-tricular hypertrophy (LVH) but not HCM. Sixteen patients with HCM (48 +/- 7 yr, 44% female), 16 participants with LVH (49 +/- 5 yr, 44% female), and 61 healthy controls (CON: 52 +/- 5 yr, 52% female) completed submaximal steady-state treadmill exercise fol-lowed by a maximal exercise test. V_O2 , Q_c , SV, and arteriovenous oxygen difference were measured during rest and exercise, and Q_c/V_O2 slopes were constructed, The Q_c/V_O2 slope was blunted in HCM compared with CON and LVH [HCM 4.9 +/- 0.7 vs. CON 5.5 +/- 1.0 (P = 0.027) vs. LVH 6.0 +/- 1.0 AU (P = 0.002)] and participants with HCM had a lower SV reserve (HCM 53 +/- 33%, controls 83 +/- 33%, LVH 82 +/- 22%; HCM vs. controls P = 0.002; HCM vs. LVH P = 0.015). Despite a blunted Q_c/V_O2 slope, 75% of patients with HCM achieved >80% predicted V_O2max by augmenting a-vO2 difference at maximal exercise (16.0 +/- 0.8 mL/100 mL vs. 13.8 +/- 2.7 mL/100 mL, P = 0.021). Patients with HCM do not appropriately match Q_c to metabolic demand, primarily due to inadequate stroke volume augmentation. Despite this central limitation, many patients achieve normal exercise capacities by sig-nificantly increasing peripheral oxygen extraction. NEW & NOTEWORTHY Through state-of-the-art hemodynamic and oxygen uptake methodologies, this study found the cardiac output response to increasing metabolic demand is blunted among patients with hypertrophic cardiomyopathy (HCM), primarily due to a reduced stroke volume reserve. Many patients with HCM augment their peripheral oxygen extraction during maximal exercise to achieve normal exercise capacity and overcome ineffective matching of cardiac output. Peripheral adaptations that compensate for cardiac limitations may contribute to the heterogeneity of functional limitations observed within this patient population.
引用
收藏
页码:787 / 797
页数:11
相关论文
共 50 条
  • [1] Thick Hearts Can't Keep Up: Patients With Hypertrophic Cardiomyopathy Are Centrally Limited During Submaximal and Maximal Exercise
    Dias, Katrin A.
    Hearon, Christopher M., Jr.
    Hieda, Michinari
    MacNamara, James P.
    Turer, Aslan
    Link, Mark S.
    Sarma, Satyam
    Levine, Benjamin D.
    CIRCULATION, 2019, 140
  • [2] Exercise for Patients With Hypertrophic Cardiomyopathy
    Soriano-Maldonado, Alberto
    Vargas-Hitos, Jose A.
    Jimenez-Jaimez, Juan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (05): : 480 - 481
  • [3] Exercise for Patients With Hypertrophic Cardiomyopathy
    Nakayama, Atsuko
    Morita, Hiroyuki
    Nagayama, Masatoshi
    Isobe, Mitsuaki
    Komuro, Issei
    CIRCULATION, 2019, 140
  • [4] Lactate kinetics at maximal and submaximal exercise in patients with sarcoidosis
    Vonbank, Karin
    Zacher, Sophia
    Mondrzyk, Jerzy
    Marzluf, Beatrice
    Idzko, Marco
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 (19-20) : 620 - 621
  • [5] Metabolic exercise testing in hypertrophic cardiomyopathy: Relation of submaximal parameters to clinical features
    Sharma, S
    Elliott, P
    Whyte, G
    Prasad, K
    Varnava, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 484A - 484A
  • [6] Vigorous exercise in patients with hypertrophic cardiomyopathy
    Dejgaard, Lars A.
    Haland, Trine F.
    Lie, Oyvind H.
    Ribe, Margareth
    Bjune, Thea
    Leren, Ida Skrinde
    Berge, Knut Erik
    Edvardsen, Thor
    Haugaa, Kristina H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 250 : 157 - 163
  • [7] Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy
    Lampert, Rachel
    Ackerman, Michael J.
    Marino, Bradley S.
    Burg, Matthew
    Ainsworth, Barbara
    Salberg, Lisa
    Esteban, Maria Teresa Tome
    Ho, Carolyn Y.
    Abraham, Roselle
    Balaji, Seshadri
    Barth, Cheryl
    Berul, Charles I.
    Bos, Martijn
    Cannom, David
    Choudhury, Lubna
    Concannon, Maryann
    Cooper, Robert
    Czosek, Richard J.
    Dubin, Anne M.
    Dziura, James
    Eidem, Benjamin
    Emery, Michael S.
    Estes, N. A. Mark
    Etheridge, Susan P.
    Geske, Jeffrey B.
    Gray, Belinda
    Hall, Kevin
    Harmon, Kimberly G.
    James, Cynthia A.
    Lal, Ashwin K.
    Law, Ian H.
    Li, Fangyong
    Link, Mark S.
    McKenna, William J.
    Molossi, Silvana
    Olshansky, Brian
    Ommen, Steven R.
    Saarel, Elizabeth V.
    Saberi, Sara
    Simone, Laura
    Tomaselli, Gordon
    Ware, James S.
    Zipes, Douglas P.
    Day, Sharlene M.
    JAMA CARDIOLOGY, 2023, 8 (06) : 595 - 605
  • [8] Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy
    Fox, Nolan
    Fox, Nicholas
    Jacobsen, Alan P.
    Blumenthal, Roger S.
    Barouch, Lili A.
    CURRENT SPORTS MEDICINE REPORTS, 2024, 23 (07) : 270 - 274
  • [9] Exercise recommendations for patients with hypertrophic cardiomyopathy
    Bryde, Robyn
    Martinez, Matthew W.
    Emery, Michael S.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 80 : 53 - 59
  • [10] Exercise for Patients With Hypertrophic Cardiomyopathy Reply
    Saberi, Sara
    Wheeler, Matthew
    Day, Sharlene M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (05): : 481 - 482